Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

EC pricing and reimbursement efficiency plans

The European Commission (EC) is working to help medicines reach the market quicker by streamlining the pricing and reimbursement process

- PMLiVE

NICE in U-turn on Novartis’ Lucentis in diabetic macular oedema

Patient access scheme influences draft recommendation

- PMLiVE

The evolving landscape of medical education, part three

Who are we trying to educate?

- PMLiVE

Ruder Finn launches a social media meningitis campaign

The awareness campaign involves collaboration with three UK meningitis charities

Teva pulls generic version of antidepressant Wellbutrin XL in US

FDA says copy is not equivalent to branded drug

- PMLiVE

Sanofi acquires Colombian pharma manufacturing firm Genfar

Expands its Latin American generics portfolio

Shionogi-ViiV to file HIV drug dolutegravir for approval

GSK, Pfizer and Shionogi joint venture completes phase III trials programme

- PMLiVE

Merck & Co says Januvia follow-up looking good

Diabetes drug shows promise in phase II as once-weekly treatment

Kantar Health appoints IMS Health’s Gary Gatyas to lead communications role

Appointed senior VP, global marketing and communications

- PMLiVE

Totality of reward: understanding human behaviour

Esme Holt, research director at Healthcare Research Worldwide, explores how research techniques can help us understand behaviours

Novartis’ COPD drug Seebri cleared in EU and Japan

Used with Breezhaler device in Europe and inhalation capsule in Japan

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links